Back to mobile site

More on VERU

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (9.0 Score)

Upcoming Events

- Earnings (11/26/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Veru, Inc. (NQ:VERU)
Delayed: 2.42 -0.04 (1.63%)
Prev. Close $2.46  
Open$2.44 
52 Wk High$ 
52 Wk Low$ 
Day High$2.45 
Day Low$2.41 
P/E N/A  
EPS$ 
Volume62,834 

Friends, Peers and Foes (?): NVO (more...)

Oct 6, 2026 01:59 PM Westlake Securities Starts Veru, Inc. (VERU) at Buy
Aug 17, 2026 04:26 PM Form 4 VERU INC. For: Aug 13 Filed by: BARNETTE K GARY
Aug 10, 2026 08:52 AM Form 10-Q VERU INC. For: Jun 30
Aug 10, 2026 08:13 AM Veru, Inc. (VERU) Tops Q3 EPS by 1c
Aug 10, 2026 07:00 AM Form 8-K VERU INC. For: Aug 10
Aug 10, 2026 06:30 AM Veru posts Q3 loss, reports full enrollment in obesity drug trial
Aug 10, 2026 06:30 AM Veru Reports Fiscal 2026 Third Quarter Financial Results and Phase 2b PLATEAU Clinical Trial Progress
Aug 4, 2026 08:30 AM Veru receives patent allowance for enobosarm and semaglutide combo
Aug 4, 2026 08:30 AM Veru Announces Notice of Allowance for Key Methods of Use U.S. Patent for Enobosarm in Combination with Semaglutide for Quality Weight Loss
Aug 3, 2026 08:30 AM Veru to Report Fiscal 2026 Third Quarter Financial Results on August 10th
View All Articles

Entities mentioned with VERU

View All Entities